Clinical Trial Search

Primary: Feasibility and Safety Using an Improved, More Efficient and Less Labor Intensive Cooling Balloon in Patients Undergoing Hypothermic Nerve-sparing RLP in Participants…

Primary: Percentage of Participants With 2-year Progression Free Survival (PFS) — 71.6; 72.3 percentage of participants

Primary: Median Yield of Robot Assisted and Second Look Open Pelvic Lymph Node Dissection to Compare the Lymph Node Yield Achieved — 43; 4 Nodes (Node Yield)

Primary: Urinary Continence Recovery — 25; 5 grams

Primary: Number of Continent Patients Post Prostatectomy — 37; 32 participants

Primary: Health Related Quality of Life (HRQoL) — 0.34; 0.30; 0.66; 0.48 scores on a scale — p=0.011

Primary: Successful Completion of the Surgical Procedure — 3 Participants

Primary: Maximum Intraocular Pressure During RALRP Under Deep Neuromuscular Blockade — 23.3; 19.8 mmHg

Primary: The Duration of Abdominal Analgesia From Infiltration Into the TAP — 0.39; 0.44 hours

Primary: Catheter Related Pain: Visual Analog Score Rating — 2.67; 2.67 score on a scale

Primary: Completion Rate — 20; 19 Participants

Primary: Number of Participants With Adequate Exposure and Access to Oropharyngeal and Hypopharyngeal Head and Neck Lesions — 147; 23 participants

Primary: Operative Time — 106.6; 101.6 minutes — p=0.71

Primary: The Area of the Transperineal Targeted Microwave Ablation (TMA) Induced Tissue Death Assessed by Triphenyltetrazolium Chloride (TTC) Staining

Primary: Positioning Effectiveness as Determined by Confirmatory Measurements of Robotic Movements — 0.489 millimeters

Primary: Duration of Surgery — 75; 106 minutes

Primary: International Prostate Symptom Score (IPSS) Change — -17.5 units on a scale

Primary: Incidence of Clavien-Dindo Adverse Events (Percentage of Participants) Through 3 Months Post Treatment — 45.5 percentage

Primary: Negative Biopsy Rate at 6 Months After Focal Bipolar Radio-Frequency Ablation (RFA) — 3; 2; 1 Participants

Primary: Change in Number of Subjects With Adverse Events Will be Collected — 22; 18; 17 Participants

Primary: Sensitivity of PSMA-PET and MRI Imaging Preoperatively for Predicting Extra-prostatic Extension — 86; 57 percentage — p=<0.05

Primary: Combined pCR or MRD Rate [Part 1] — 12; 12 Participants

Primary: Proportion of Subjects With Adverse Events (Clavien-Dindo Grading System Grade 2 or Higher or Any Grade 1 Event Resulting in Persistent Disability) — 26; 42 percentage…

Primary: Number of Tools Required to Retract the Prostate During Procedure — 0 Additional Tools to Mobilize Liver

Primary: Safety of Using Platelet Rich Plasma (PRP) on the Neurovascular Bundle (NVB) — 0; 2; 17 Participants

Primary: Absence of Clinically Significant Cancer (CSC) on Control Biopsy at 1-year Follow-up. — 8 Participants

Primary: Number of Participants With One Grade 1 Adverse Event, More Than One Grade 1 Adverse Event, and One Grade 2 Adverse Event — 4; 2; 4 Participants

Primary: Accuracy of Acetabular Cup Placement Manually vs. Robotic-arm Assisted - Version. — 5.95; 4.26 degrees error in anteversion

Primary: The Purpose of the Present Study is to Assess the Safety of PS-341 as a Pretreatment in Patients Who Are to Undergo a Radical Prostatectomy. Poor Wound Healing and…

Primary: Percentage of Patients Who Can Safely Tolerate and Complete Adjuvant Hormonal Therapy, Radiation Therapy and Docetaxel After a Radical Prostatectomy — 26 percentage of…